Biceltis 440 mg Injection
USES
The injection Biceltis 440mg is used alone or combination with other medicine for the treatment in patients who suffering from metastatic breast cancer.The drug also indicated with combination of other medicine for the treatment of certain types of stomach or esophagus cancer in some persons.
WORK AS
Different type of breast cancer cells has a higher than normal level of a protein called HER2 (human epidermal growth factor receptor 2) on their surface. These HER2 receptors get signals which stimulate the tumor cells to develop and reproduce. But breast cancer cells with too many HER2 receptors can Choice too many growth signals and so start developing and proliferating too much and too fast.
Biceltis 440mg acts by adhere itself to the HER2 receptors on the surface of breast cancer cells and stopping them from collecting growth signals. By stopping the signals, Biceltis 440mg can slow or inhibit the growth of the breast cancer and the drug is an immune targeted therapy. In addition to inhibiting HER2 receptors, Trastuzumab can also help to fight against breast cancer by attentive the immune system to damage the cancer cells onto which it is attached.
Biceltis 440mg acts by adhere itself to the HER2 receptors on the surface of breast cancer cells and stopping them from collecting growth signals. By stopping the signals, Biceltis 440mg can slow or inhibit the growth of the breast cancer and the drug is an immune targeted therapy. In addition to inhibiting HER2 receptors, Trastuzumab can also help to fight against breast cancer by attentive the immune system to damage the cancer cells onto which it is attached.
Adjuvant treatment, breast cancer:
The drug given according to one of the following doses and schedules for a 52 weeks total of trastuzumab treatment:
During combination with paclitaxel, docetaxel, or docetaxel /Carboplatin:
Starting dose of 4 mg/kg as an IV (intravenous infusion) over 90 minutes followed at 2 mg/kg as an IV(intravenous infusion) over 30 minutes weekly during treatment of chemotherapy given with paclitaxel or docetaxel for first 12 weeks or 18 weeks (docetaxel/carboplatin) The Biceltis 440mg dose for One week following the last weekly administers Trastuzumab at 6 mg/kg as an IV (intravenous infusion) over 30 to 90 minutes every three weeks.
The injection given as a single agent within three weeks following completion of multi-modality, anthracycline-based chemotherapy regimens: For an intravenous infusion over 90 minutes: Initial dose at 8 mg/kg Successive doses at 6 mg/kg over 30 to 90 minutes every three weeks as an intravenous infusion. Adjuvant treatment stretching beyond one year is not recommended.
 |
| Biceltis 440mg |
Metastatic Treatment, Breast Cancer:
Biceltis 440mg administrated alone or in combination with paclitaxel, at a starting dose of 4 mg/kg as a 90-minute intravenous infusion continued by successive once weekly doses of 2 mg/kg as 30-minute intravenous infusions until disease development.Metastatic Gastric Cancer:
Biceltis 440mg administrated at a starting dose of 8 mg/kg as a 90-minute IV intravenous infusion continued by successive doses of 6 mg/kg as an intravenous infusion over 30 to 90 minutes every three weeks until disease development.DRUG INTERACTION
In some phenomenal condition, patient should get anthracycline, in that situation patient’s cardiac function should be checked carefully with regular intervals. Do not take anthracycline treatment for 7 months after stopping the Biceltis 440mg treatment. Biceltis 440mg interaction with anthracycline after ending of Biceltis 440mg treatment may have a chance of getting cardiac problem. This side effects occur because of Trastuzumab great disaster period is depends on population PK analysis.MISSED DOSE
The drug Missing doses can decrease their usefulness and raises the probability of developing drug resistance, that makes this drug lose their potency. For best results, it is important to accept each scheduled dose of Trastuzumab medication as instructed. If you miss a dose, leave the missed dose and continue with your regular dosing schedule. Do not have two doses to make up for a missed one. If you are not sure about what to do after missing a dose, the take advice with doctor or pharmacist.CONTRAINDICATION
Probably no contraindicated occurs. The patients are contraindicated to the component present in the Biceltis 440mg, Hence Hypersensitivity reactions are occurring.STORAGE
Store the drug at 2℃ to 8℃ (refrigerator temperature) Protected the vial away from heat & lightStored at 2℃ to 8℃ for 28 days after reconstitution Stored Biceltis 440mg diluted bag at 2℃ to 8℃ for 24 hours. |
| Biceltis 440mg injection |
SIDE EFFECTS
- Common side effects:
- Redness at injection site (IV)
- Muscle/joint/back pain
- Insomnia
- Tiredness
- Mild skin rash
- Stuffy nose
- Sinus pain
- Serious side effects:
- Increased coughing
- Sudden unexplained weight gain
- Unusual tiredness
- Easy bruising or bleeding
Phone Number
+91-9987711567
URL
Email ID
applepharamaceutical@gmail.com
info@myapplepharma.com
Comments
Post a Comment